- Global Pharma News & Resources

Cell Expansion Market 2019-2026: Sales Revenue, Growing CAGR Values, Industry Segments Analysis and Global Trends, Top Leaders, Strategy Profiling, Regional Statistics

Cell expansion is the process of producing daughter cells from a single cell in an artificial environment for medical research purpose. Emerging regenerative medicine field coupled with the emergence of cell-based therapies are the prime factor fueling the market growth of cell expansion over the forecast period (2019-2027). Regenerative medicine is gaining traction in the market as it helps to generate new functional tissue to replace defective or lost ones.

According to the U.S. Department of Health and Services, in 2016, NIH invested around US$ 1.5 billion in stem cell research projects. Increasing government and private sector expenditure on cell-based research therapies is expected to boost the growth of the market for cell expansion in the near future. Moreover, FDA approval for clinical trials of stem-cell-based treatment is rapidly increasing. According to a report published by Pharmaceutical Research and Manufacturers of America, in 2013, around 69 cell therapies with clinical trials were under review with the FDA. The therapeutic classes represented in these trials include skin diseases, cardiovascular diseases, transplantations, eye conditions, cancer and associated conditions, musculoskeletal disorders, genetic disorders, and digestive disorders.

To understand Research Methodology, please click

Rising cases of chronic disease is assumed to fuel the growth of the cell expansion market during the forecast timeline

Rising cases of chronic and rare disease across the globe is another major factor propeling the market growth of cell expansion. For instance, according to World Health Organization (WHO), around 15 million people are projected to suffer from cancer by 2020. Therefore, the rising case of cancer around the globe is further projected to augment the growth of the cell expansion market. Moreover, emerging cell-based therapy is also expected to show a promising approach for treating chronic kidney disease and is currently focusing on the preclinical studies. New technological advancement in regenerative medicine and tissue engineering have created lost of opportunities for the cell-based approaches for the treatment of renal failure. Such treatments cover biotechnological fields using implantation of transplanting cells, bioengineered kidney constructs, and bio-artificial renal systems. On the other side, lack of skilled professionals and high-tech instrumentation along with the high cost associated with the operations are presumed to curb the market growth of cell expansion.

Get Discount For Buyers UPTO 25% OFF On Any Research Report
Apply Promo Code “CHRISTMAS2020” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @

Market Segmentation

By Product Type

  • Consumables
  • Reagents, Serum, and Media
  • Disposables
  • Equipment
    • Cell Expansion Supporting Equipment
      • Flow Cytometer
      • Cell Counters
      • Centrifuges
      • Other Supporting Equipment
    • Bioreactors
    • Automated Cell Expansion Systems

By Application

  • Regenerative Medicine and Stem Cell Research
  • Cancer and Cell-based Research
  • Others

By Cell Type

  • Human Cells
    • Stem Cells
      • Adult Stem Cells
      • Induced Pluripotent Stem Cells
      • Embryonic Stem Cells
    • Differentiated Cells
  • Animal Cells

By End-user

  • Research Institutes
  • Biopharmaceutical and Biotechnology Companies
  • Cell Banks
  • Others

Request for the trending sample of this report:

North America is projected to hold the largest share in the cell expansion market owing to the emerging field of regenerative medicines and growing incidence of chronic disease

From the geographical point of view, the cell expansion market by Coherent Market Insights covers North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The growth of North America cell expansion market is propelling by rising demand for regenerative medicines which are highly compatible with patients as it offers rapid result. For instance, the FDA is increasingly approving treatments involving cells derived from bone or blood marrow, due to its well-established efficacy and safety. Moreover, rising incidence of chronic cases along with growing R&D investment for the production of cell-based therapies is some of the other reasons augmenting the market growth of cell expansion. According to a study published in NIH report, around 500,000 people benefit from a transplant each year using regenerative medicine in the U.S. Rising investment on R&D by the various manufacturer the developing new therapeutic products and untapped growth opportunities are further projected to boost the cell expansion market in the Asia Pacific. Also, rising merger and acquisition between biotechnology industries is further presumed to accelerate the market growth. According to investment bank China Renaissance, in 2016, 37 pharmaceutical and biotech M&A deals worth US$ 6.8 billion were closed in China.

Key industry players use merger and acquisitions as their major growth strategy

Key players operating in the cell expansion market include Becton, Dickinson and Company, Beckman Coulter, Inc., Corning, Inc., GE Healthcare, Lonza, Merck KGaA (Sigma-Aldrich Co. LLC), Miltenyi Biotec, Thermo Fisher Scientific, Inc., Terumo BCT, Inc., and Stemcell Technologies, Inc. In July 2016, GE Healthcare acquired Biosafe SA, a Swiss company that manufactures instruments that recover stem cells and help in various other cell processing procedures related to personalized medicine. This acquisition will help GE Healthcare to grow the cells in the sample for appropriate dose sizes.

Other Related Reports:

Cell Surface Markers Market, By Product Type, By Application, and By Region – Size, Share Outlook, and Opportunity Analysis, 2020 – 2027

Breathalyzers Market, By Technology, by Application, and By Region – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

Cancer Biologics Market, by Product, by Application, by Distribution Channel, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website –


Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 08-Dec-2020